Back
Seelos Therapeutics Vs. Citius Pharmaceuticals Industry Stock Comparison
Sell
7
SEEL
Seelos Therapeutics
Last Price:
0.20
Seasonality Move:
-7.57%
Sell
21
CTXR
Citius Pharmaceuticals
Last Price:
0.56
Seasonality Move:
-8.52%
Sell
7
Seelos Therapeutics (SEEL)
is a Sell
Is Seelos Therapeutics a Buy, Sell or Hold?
- The current Seelos Therapeutics [SEEL] share price is $0.20. The Score for SEEL is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
- SEEL is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
21
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy, Sell or Hold?
- The current Citius Pharmaceuticals [CTXR] share price is $0.57. The Score for CTXR is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- CTXR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SEEL Stock Price Chart
What is Seelos Therapeutics's stock price today?
-
The Seelos Therapeutics share price today is $0.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SEEL is experiencing slight buying pressure.
CTXR Stock Price Chart
What is Citius Pharmaceuticals's stock price today?
-
The Citius Pharmaceuticals share price today is $0.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.
SEEL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 37.16 | Sell |
Chaikin Money Flow: | 306592 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.19 - 0.33) | Sell |
Bollinger Bands (100): | (0.13 - 1.53) | Sell |
CTXR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 47.64 | Sell |
Chaikin Money Flow: | 1049687 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.52 - 0.6) | Buy |
Bollinger Bands (100): | (0.55 - 0.81) | Sell |
SEEL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.2 | Buy |
20-day SMA: | 0.24 | Sell |
50-day SMA: | 0.33 | Sell |
200-day SMA: | 4.38 | Sell |
8-day EMA: | 0.21 | Sell |
20-day EMA: | 0.24 | Sell |
50-day EMA: | 0.47 | Sell |
200-day EMA: | 24.16 | Sell |
CTXR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.53 | Buy |
20-day SMA: | 0.55 | Buy |
50-day SMA: | 0.7 | Sell |
200-day SMA: | 0.72 | Sell |
8-day EMA: | 0.54 | Buy |
20-day EMA: | 0.56 | Buy |
50-day EMA: | 0.63 | Sell |
200-day EMA: | 0.73 | Sell |
Seelos Therapeutics Earnings Growth & SEEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $16.80 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.10 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Seelos Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Citius Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |